3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
22
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer
2
Non-metastatic, Hormone naïve Prostate Cancer
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Hormone Sensitive Prostate Cancer
1
Adenocarcinoma of the Prostate
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Androgen Antagonists
×
Clear all
No trials found.